Blue Ivy Ventures — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Earli develops a biotechnology platform that uses genetic constructs to detect cancer and produce therapeutic proteins by reprogramming cancer cells.
AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
Dr. Sam Gambhir(Founder)Cyriac Roeding(Founder)inDr. David Suhy(Co-founder & Chief Scientific Officer)
BoardJustin Kao(Director)inJorge Conde(Director)in
Co-investorsAlumni VenturesAndreessen HorowitzBreyer CapitalGaingelsHan River PartnersIKJ Capital+7 more
Printify is a print-on-demand platform that enables entrepreneurs to build eCommerce businesses by connecting them with a global network of printing providers.
B2B MarketplacesCreator EconomyDirect to ConsumerE-commerceLogistics & Supply ChainSaaSWilmington, US
Janis Berdigans(Executive Officer, Director)inGatis Dukurs(Founder)inJames Janis Berdigans(Founder)inArtis Kehris(Founder)inEdgars Peics(Executive Officer)inArtis Grizans(Executive Officer)in
Co-investors500 GlobalAlleyCorpAlumni VenturesBling CapitalChange VenturesDreamers VC+8 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





__Twitter.png)











